This grant from the National Institute of Arthritis and Musculoskeletal and Skin Diseases aims to support the development of creative and short-term interventional clinical trials for patients with rheumatic, musculoskeletal, or skin diseases. The trials should focus on innovative research questions and investigate new ideas using various interventions like drugs, biologics, devices, or therapies. The goal is to gather experimental data to pave the way for future more extensive clinical trials, contributing valuable insights to clinical decision-making for patient care. Closing date for applications is March 1, 2017.
Opportunity ID: 254258
General Information
Document Type: | Grants Notice |
Funding Opportunity Number: | PAR-14-192 |
Funding Opportunity Title: | Exploratory Clinical Trial Grants in Arthritis and Musculoskeletal and Skin Diseases (R21) |
Opportunity Category: | Discretionary |
Opportunity Category Explanation: | – |
Funding Instrument Type: | Grant |
Category of Funding Activity: | Health |
Category Explanation: | – |
Expected Number of Awards: | – |
Assistance Listings: | 93.846 — Arthritis, Musculoskeletal and Skin Diseases Research |
Cost Sharing or Matching Requirement: | No |
Version: | Synopsis 1 |
Posted Date: | Apr 24, 2014 |
Last Updated Date: | – |
Original Closing Date for Applications: | Mar 01, 2017 |
Current Closing Date for Applications: | Mar 01, 2017 |
Archive Date: | Apr 01, 2017 |
Estimated Total Program Funding: | – |
Award Ceiling: | $400,000 |
Award Floor: | – |
Eligibility
Eligible Applicants: | Others (see text field entitled “Additional Information on Eligibility” for clarification) Private institutions of higher education Small businesses Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education County governments Special district governments Public and State controlled institutions of higher education Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Independent school districts Native American tribal organizations (other than Federally recognized tribal governments) Public housing authorities/Indian housing authorities Native American tribal governments (Federally recognized) For profit organizations other than small businesses State governments City or township governments |
Additional Information on Eligibility: | Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are allowed. |
Additional Information
Agency Name: | National Institutes of Health |
Description: | The goal of this FOA is to foster the development and implementation of interventional exploratory clinical trials aimed at providing clinically meaningful improvements in symptoms, function or disease course for patients with rheumatic, musculoskeletal or skin diseases. The trials must address research questions related to the mission and goals of the NIAMS and may evaluate drugs, biologics, devices, or surgical, dietary, behavioral or rehabilitation therapies. This Exploratory Clinical Trials Grants Program is designed to facilitate the execution of creative, short-term interventional studies to obtain the experimental data needed to launch future clinical trials. The proposed trials should strive to investigate new ideas and may use creative trial designs. Proposed studies should focus on research questions that have the potential to contribute critical clinically-relevant data in support of a future, more robust clinical trial, or that can impact and benefit clinical decision making at the patient level. |
Link to Additional Information: | http://grants.nih.gov/grants/guide/pa-files/PAR-14-192.html |
Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV Email:FBOWebmaster@OD.NIH.GOV |
Version History
Version | Modification Description | Updated Date |
---|---|---|
Related Documents
There are no related documents on this grant.
Packages
Agency Contact Information: | NIH OER Webmaster FBOWebmaster@OD.NIH.GOV Email: FBOWebmaster@OD.NIH.GOV |
Who Can Apply: | Organization Applicants |
Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
---|---|---|---|---|---|---|
FORMS-C | Forms-C | PKG00195730 | Jun 02, 2014 | Apr 29, 2016 | View | |
FORMS-D | Use for due dates on or after May 25, 2016 | PKG00223097 | Jun 01, 2016 | Mar 01, 2017 | View |
Package 1
Mandatory forms
254258 RR_SF424_2_0-2.0.pdf
254258 PHS398_ResearchPlan_2_0-2.0.pdf
254258 PHS398_CoverPageSupplement_2_0-2.0.pdf
254258 RR_KeyPersonExpanded_2_0-2.0.pdf
254258 RR_OtherProjectInfo_1_3-1.3.pdf
254258 PerformanceSite_2_0-2.0.pdf
Optional forms
254258 RR_SubawardBudget30_1_3-1.3.pdf
254258 PlannedReport-1.0.pdf
254258 PHS398_CumulativeInclusionReport-1.0.pdf
254258 PHS398_ModularBudget_1_2-1.2.pdf
254258 RR_Budget_1_3-1.3.pdf
Package 2
Mandatory forms
254258 RR_SF424_2_0-2.0.pdf
254258 PHS398_CoverPageSupplement_3_0-3.0.pdf
254258 RR_OtherProjectInfo_1_3-1.3.pdf
254258 PerformanceSite_2_0-2.0.pdf
254258 RR_KeyPersonExpanded_2_0-2.0.pdf
254258 PHS398_ResearchPlan_3_0-3.0.pdf
Optional forms
254258 RR_Budget_1_3-1.3.pdf
254258 RR_SubawardBudget30_1_3-1.3.pdf
254258 PHS398_ModularBudget_1_2-1.2.pdf
254258 PHS_Inclusion_Enrollment_Report-1.0.pdf
254258 PHS_AssignmentRequestForm-1.0.pdf